Follow
Nola Hylton
Nola Hylton
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
I‐SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy
AD Barker, CC Sigman, GJ Kelloff, NM Hylton, DA Berry, LJ Esserman
Clinical Pharmacology & Therapeutics 86 (1), 97-100, 2009
7912009
Diagnostic Architectural and Dynamic Features at Breast MR Imaging: Multicenter Study1
MD Schnall, J Blume, DA Bluemke, GA DeAngelis, N DeBruhl, S Harms, ...
Radiology 238 (1), 42-53, 2006
6742006
Magnetic resonance imaging of the breast prior to biopsy
DA Bluemke, CA Gatsonis, MH Chen, GA DeAngelis, N DeBruhl, S Harms, ...
Jama 292 (22), 2735-2742, 2004
6462004
Adaptive randomization of veliparib–carboplatin treatment in breast cancer
HS Rugo, OI Olopade, A DeMichele, C Yau, LJ van’t Veer, MB Buxton, ...
New England Journal of Medicine 375 (1), 23-34, 2016
5672016
Effect of pembrolizumab plus neoadjuvant chemotherapy on pathologic complete response in women with early-stage breast cancer: an analysis of the ongoing phase 2 adaptively …
R Nanda, MC Liu, C Yau, R Shatsky, L Pusztai, A Wallace, AJ Chien, ...
JAMA oncology 6 (5), 676-684, 2020
5102020
Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging
L Esserman, N Hylton, L Yassa, J Barclay, S Frankel, E Sickles
Journal of clinical oncology 17 (1), 110-110, 1999
5101999
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy—results from ACRIN 6657/I-SPY TRIAL
NM Hylton, JD Blume, WK Bernreuter, ED Pisano, MA Rosen, EA Morris, ...
Radiology 263 (3), 663-672, 2012
5062012
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging
CD Lehman, JD Blume, P Weatherall, D Thickman, N Hylton, E Warner, ...
Cancer 103 (9), 1898-1905, 2005
4872005
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker
N Hylton
Journal of clinical oncology 24 (20), 3293-3298, 2006
4862006
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657
LJ Esserman, DA Berry, A DeMichele, L Carey, SE Davis, M Buxton, ...
Journal of Clinical Oncology 30 (26), 3242, 2012
4802012
Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy
SC Partridge, JE Gibbs, Y Lu, LJ Esserman, D Sudilovsky, NM Hylton
American Journal of Roentgenology 179 (5), 1193-1199, 2002
4072002
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
LJ Esserman, DA Berry, MCU Cheang, C Yau, CM Perou, L Carey, ...
Breast cancer research and treatment 132, 1049-1062, 2012
3682012
Adaptive randomization of neratinib in early breast cancer
JW Park, MC Liu, D Yee, C Yau, LJ van’t Veer, WF Symmans, M Paoloni, ...
New England Journal of Medicine 375 (1), 11-22, 2016
3522016
MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival
SC Partridge, JE Gibbs, Y Lu, LJ Esserman, D Tripathy, DS Wolverton, ...
AJR Am J Roentgenol 184 (6), 1774-1781, 2005
3312005
Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability
K Kinkel, TH Helbich, LJ Esserman, J Barclay, EH Schwerin, EA Sickles, ...
American journal of Roentgenology 175 (1), 35-43, 2000
3202000
Development, standardization, and testing of a lexicon for reporting contrast‐enhanced breast magnetic resonance imaging studies
DM Ikeda, NM Hylton, K Kinkel, MG Hochman, CK Kuhl, WA Kaiser, ...
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2001
2982001
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference
TA Buchholz, CD Lehman, JR Harris, BA Pockaj, N Khouri, NF Hylton, ...
Journal of Clinical Oncology 26 (5), 791-797, 2008
2612008
Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): results from I-SPY 2.
R Nanda, MC Liu, C Yau, S Asare, N Hylton, LV Veer, J Perlmutter, ...
Journal of Clinical Oncology 35 (15_suppl), 506-506, 2017
2462017
Neoadjuvant chemotherapy for breast cancer: functional tumor volume by MR imaging predicts recurrence-free survival—results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL
NM Hylton, CA Gatsonis, MA Rosen, CD Lehman, DC Newitt, ...
Radiology 279 (1), 44-55, 2016
2452016
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
ER Garwood, AS Kumar, FL Baehner, DH Moore, A Au, N Hylton, ...
Breast cancer research and treatment 119, 137-144, 2010
2342010
The system can't perform the operation now. Try again later.
Articles 1–20